Lambert-Eaton Myasthenic Syndrome Secondary to Nivolumab and Ipilimumab in a Patient With Small-Cell Lung Cancer

Case Reports in Neurological Medicine
doi 10.1155/2019/5353202
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

The Association Between Lambert–Eaton Myasthenic Syndrome and Small Cell Lung Carcinoma

ImmunoTargets and Therapy
AllergyImmunology
2013English

Long Term Outcome in Lambert-Eaton Myasthenic Syndrome Without Lung Cancer

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
2001English

A Lambert-Eaton Myasthenic Syndrome Antigen Associated With Presynaptic Calcium Channels

Biochemical Society Transactions
Biochemistry
1993English

Lung Adenocarcinoma With Lambert–Eaton Myasthenic Syndrome Indicated by Voltage-Gated Calcium Channel: A Case Report

Journal of Medical Case Reports
Medicine
2012English

SOX1 Antibodies Are Markers of Paraneoplastic Lambert-Eaton Myasthenic Syndrome

Neurology
Neurology
2007English

An Abscopal Response to Radiation and Ipilimumab in a Patient With Metastatic Non-Small Cell Lung Cancer

Cancer immunology research
Cancer ResearchImmunology
2013English

Nivolumab Monotherapy and Nivolumab Plus Ipilimumab in Recurrent Small Cell Lung Cancer: Results From the CheckMate 032 Randomized Cohort

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2020English

Long‐term Follow‐up, Quality of Life, and Survival of Patients With Lambert‐Eaton Myasthenic Syndrome

Neurology
Neurology
2019English

P2.12-16 Significant Tumor Regression and Toxicity With Nivolumab Plus Ipilimumab in Small Cell Lung Cancer Patients Following Radiation

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy